Actionable news
All posts from Actionable news
Actionable news in PFE: PFIZER Inc,

Pfizer's XALKORI successful in late-stage lung cancer study in Asian patients

Results from a Phase 3 clinical trial, PROFILE 1029, in treatment-naive East Asian patients with ALK-positive advanced non-small cell lung cancer (NSCLC) show treatment with Pfizer's (NYSE:PFE)...